Since the early 1980s when the company Roche put Isotretinoin on the market under the brand name Accutane, programs have been implemented to prevent patients from getting pregnant while on it. Some of these have included the Accutane Pregnancy Prevention Program, the System to Manage Accutane Related Teratogenicity and iPledge programs.